Andrew Hill Investment Advisors Inc. Makes New $1.51 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Andrew Hill Investment Advisors Inc. acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,460 shares of the medical equipment provider’s stock, valued at approximately $1,505,000. Intuitive Surgical accounts for 1.6% of Andrew Hill Investment Advisors Inc.’s investment portfolio, making the stock its 28th largest holding.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. OFI Invest Asset Management bought a new position in Intuitive Surgical in the third quarter worth approximately $25,000. Baystate Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. Headinvest LLC acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $28,000. Stone House Investment Management LLC increased its stake in Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC bought a new stake in Intuitive Surgical during the 3rd quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Citigroup lifted their price objective on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Jefferies Financial Group increased their price target on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday. Finally, Robert W. Baird dropped their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $378.48.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,318 shares of the firm’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the transaction, the executive vice president now directly owns 189 shares of the company’s stock, valued at $69,958.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the sale, the executive vice president now directly owns 189 shares in the company, valued at $69,958.35. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the completion of the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock valued at $95,927,097 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Down 1.2 %

Shares of ISRG stock traded down $4.40 on Friday, hitting $368.23. 1,902,390 shares of the stock were exchanged, compared to its average volume of 1,647,296. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The firm’s 50 day moving average is $387.27 and its two-hundred day moving average is $342.60. The firm has a market capitalization of $130.52 billion, a PE ratio of 75.96, a P/E/G ratio of 5.81 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company’s revenue was up 11.5% on a year-over-year basis. During the same quarter last year, the company earned $1.00 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.